ConductScience.org, home

Paper4584153

Kinetics of warfarin absorption in man.

Breckenridge A and 1 other. Clin Pharmacol Ther, 1973. Cited by 74 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Kinetics of warfarin absorption in man. Papers, record 4584153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4584153

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kinetics of warfarin absorption in man.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1973
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
3.85
iCite
Revised in PubMed
2019-05-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Breckenridge AA
2Orme MM

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
WarfarinMajor topic
Administration, Oral
Adult
Aged
Carbon Radioisotopes
Clinical Trials as Topic
Humans
Injections, Intravenous
Intestinal Absorption
Kinetics
Middle Aged
Time Factors

Source PubMed

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
42,647,228Warfarin-Induced Developmental Toxicity: Insights into Embryogenesis, Teratogenicity, and Molecular Pathways.J Dev Biol2026https://conductscience.org/library/papers/42647228PubMed
35,138,605Effects and Mechanism of Action of Panax notoginseng Saponins on the Pharmacokinetics of Warfarin.Eur J Drug Metab Pharmacokinet2022https://conductscience.org/library/papers/35138605PubMed
28,665,355In Silico Prediction for Intestinal Absorption and Brain Penetration of Chemical Pesticides in Humans.Int J Environ Res Public Health2017https://conductscience.org/library/papers/28665355PubMed
28,379,643Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence.CPT Pharmacometrics Syst Pharmacol2017https://conductscience.org/library/papers/28379643PubMed
23,208,322Influence of ORM1 polymorphisms on the maintenance stable warfarin dosage.Eur J Clin Pharmacol2013https://conductscience.org/library/papers/23208322PubMed
22,924,488Predicted metabolic drug clearance with increasing adult age.Br J Clin Pharmacol2013https://conductscience.org/library/papers/22924488PubMed
21,279,098Anticoagulant therapy.Can Fam Physician1984https://conductscience.org/library/papers/21279098PubMed
11,496,940Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.Pharm Res2001https://conductscience.org/library/papers/11496940PubMed
9,068,929Pharmacokinetic optimisation of the treatment of deep vein thrombosis.Clin Pharmacokinet1997https://conductscience.org/library/papers/9068929PubMed
8,983,860Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.Clin Pharmacokinet1996https://conductscience.org/library/papers/8983860PubMed
8,527,280The influence of age, liver size and enantiomer concentrations on warfarin requirements.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8527280PubMed
7,917,775Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.Br J Clin Pharmacol1994https://conductscience.org/library/papers/7917775PubMed
7,381,693Mathematical basis and generalization of the Loo-Riegelman method for the determination of in vivo drug absorption.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7381693PubMed
6,690,067Aminoglutethimide and warfarin. A new important drug interaction.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6690067PubMed
6,661,352Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6661352PubMed
6,347,619Drug interactions with warfarin.Drugs1983https://conductscience.org/library/papers/6347619PubMed
6,329,253The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6329253PubMed
4,830,225Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.J Clin Invest1974https://conductscience.org/library/papers/4830225PubMed
3,818,988Proposed classification of resistances to oral anticoagulant therapy.J Clin Pathol1987https://conductscience.org/library/papers/3818988PubMed
3,542,339Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.Clin Pharmacokinet1986https://conductscience.org/library/papers/3542339PubMed

See all 28 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4584153

GET https://conductscience.org/api/papers/v1/4584153/cited_by?page=2